<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110809007265N14</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-01</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation and comparison of the effects of electroacupuncture and manual acupuncture on uterine fibroids</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on symptoms, mass size and doppler indices of uterine arteries in patients with uterine fibroids</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-11-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71315</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization type: Block
The method used to generate the random allocation sequence: envelope method:
The envelopes will be prepared and printed by a member of the research team and random numbers with the help of Randomaize.com site, and placed inside the envelope. The lid of the envelopes will be closed and its contents will not be visible from the outside. Then the purpose of the study will be explained to the person who meets the stated conditions, and if the person wishes to continue, he will sign the informed consent form and pick an envelope, then opens it, and based on the contents of the envelope, the person will be entered into the intervention or control group.


Allocation Concealment method:
Numbered sealed envelopes

After randomly assigning each patient to one of the groups, the name of the patient and the corresponding group is recorded in a book by the allocator who will not be among the evaluators, Blinding description: The patients are blinded in all stages of the intervention and do not know which group they have participated in. 
The main researcher who performs acupuncture knows the group of patients because the treatment protocol of each group is different from the other group. 
The statistical researcher and analyzer, the radiologist who performs ultrasound Doppler and the gynecologist, who is responsible for the initial diagnosis of patients and their referral, are also blind to the groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Leiomyoma.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: In the segmental electroacupuncture group, after inserting the needles in their predefined acupoints (two points located on the abdominal myotomes with common innervation with the uterine nerves: ST28 (Shuidao) &amp; ST29 (Guilai) located on myotomes T12/L1 and two points located on the distal myotomes with common innervation with the uterine nerves: SP6 (Sanyinjiao) located on S2 myotome &amp; LIV3 (Taichong) located on S3 myotome) Bilaterally and reaching De Qi, the needles will be connected to the electroacupuncture (electrical stimulation) device (abdominal points on each side together and distal points on each side together) and will be stimulated for thirty minutes with a frequency of eighty hertz and a wavelength of one hundred And eighty microseconds and with continuous mode. The intensity of the electric current starts from three milliamps and can be increased until the patient does not feel pain. Intervention 2: Second Intervention group: In the manual acupuncture group, after inserting the needles in the specified acupoints and reaching De Qi, the needles will remain in place for thirty minutes without stimulation. acupoints of this group:LU7 (Lieque) right hand, ST25 (Tianshu), ST28 (Shuidao), ST36 (Zusanli), ST40 (Fenglong), SP4 (Gongsun) right foot, SP6 (Sanyinjiao), SP10 (Xuehai), KI6 (Zhaohai) left foot, KI14 (Siman), PC6 (Neiguan) left hand,LIV3 (Taichong), LIV8 (Ququan), CV 3 (Zhongji),CV4 (Guanyuan), CV6 (Qihai), EX-CA1 (Zigong), N-CA-18 (Tituo) In order to maintain the blinding process, the needles will be connected to the electroacupuncture device in a similar way to the first group, but no stimulation will be induced and we will only use the beep sound of the device. Intervention 3: Control group: In Sham acupuncture group, Streitberger placebo needles will be used bilaterally in the same points as in segmental electric acupuncture group. These needles do not have the ability to penetrate the skin and will enter into their handle after a gentle tap while placing them on the skin. the needle handle will be connected to the electroacupuncture machine in the same way as the electroacupuncture group, with the difference that no stimulation is induced and we will only use the beep sound of the machine to resemble the electroacupuncture model and maintain the blinding process.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on primary outcomes and secondary outcomes can be shared from the Participant Data File item.
The study protocol and clinical study report will be published in full
The informed consent form can be shared in raw form

When:
The protocol is ready to be published
Other documents are going to be published after the survey is finished

To whom:
University professors, university students and researchers

Conditions:
Application of data in order to use them in future surveys and also their application in treatment of patients

Where to obtain:
Dr.Hoda Azizi (azizih@mums.ac.ir)
Dr.Elham Hooshyarazar (hooshyare991@mums.ac.ir)

How to obtain:
An e-mail is needed to be sent to the above mentioned persons

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elham Hooshyarazar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshgah street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3854 3031</telephone>
        <email>hooshyare991@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hoda Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshgah street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3854 3031</telephone>
        <email>azizih@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Non virgin females aged 18 until menopause
Females who have uterine fibroids type 1-6 according to contemporary medicine standards
Signing the informed consent form
No need for immediate or emergency surgery intervention
Being able to come to acupuncture clinic twice a week for 8 weeks
Not suffering from adenomyosis or other genitourinary malignancies
Non pregnant and not breastfeeding
Not consuming hormonal drugs and drugs which can affect results of this study since 3 months ago
Not suffering from severe heart / hepatic / renal failure
No history of epilepsy
Not participating in other acupuncture based studies
Non smokers, not consuming alcohol
Not suffering from uncontrolled diabetes and Hypertension
Not having Hb bellow 10 mg/dl</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Mismatching with the inclusion criteria after the start of the intervention (such as the need to take hormonal drugs or emergency surgery)
Getting adenomyosis, genitourinary malignancies, severe heart/ hepatic/ renal failure and seizure during the study
Not willing to get acupuncture for any reason
Being absent from more than two consecutive treatment sessions
Getting pregnant during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>D25 Leiomy</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.Uterine fibroids are the most common non-cancerous tumors in w</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: In the segmental electroacupuncture group, after inserting the needles in their predefined acupoints (two points located on the abdominal myotomes with common innervation with the uterine nerves: ST28 (Shuidao) &amp; ST29 (Guilai) located on myotomes T12/L1 and two points located on the distal myotomes with common innervation with the uterine nerves: SP6 (Sanyinjiao) located on S2 myotome &amp; LIV3 (Taichong) located on S3 myotome) Bilaterally and reaching De Qi, the needles will be connected to the electroacupuncture (electrical stimulation) device (abdominal points on each side together and distal points on each side together) and will be stimulated for thirty minutes with a frequency of eighty hertz and a wavelength of one hundred And eighty microseconds and with continuous mode. The intensity of the electric current starts from three milliamps and can be increased until the patient does not feel pain.</i_keyword>
      <i_keyword>Second Intervention group: In the manual acupuncture group, after inserting the needles in the specified acupoints and reaching De Qi, the needles will remain in place for thirty minutes without stimulation. acupoints of this group:LU7 (Lieque) right hand, ST25 (Tianshu), ST28 (Shuidao), ST36 (Zusanli), ST40 (Fenglong), SP4 (Gongsun) right foot, SP6 (Sanyinjiao), SP10 (Xuehai), KI6 (Zhaohai) left foot, KI14 (Siman), PC6 (Neiguan) left hand,LIV3 (Taichong), LIV8 (Ququan), CV 3 (Zhongji),CV4 (Guanyuan), CV6 (Qihai), EX-CA1 (Zigong), N-CA-18 (Tituo) In order to maintain the blinding process, the needles will be connected to the electroacupuncture device in a similar way to the first group, but no stimulation will be induced and we will only use the beep sound of the device.</i_keyword>
      <i_keyword>Control group: In Sham acupuncture group, Streitberger placebo needles will be used bilaterally in the same points as in segmental electric acupuncture group. These needles do not have the ability to penetrate the skin and will enter into their handle after a gentle tap while placing them on the skin. the needle handle will be connected to the electroacupuncture machine in the same way as the electroacupuncture group, with the difference that no stimulation is induced and we will only use the beep sound of the machine to resemble the electroacupuncture model and maintain the blinding process.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on mass size of dominant uterine fibroids before, immediately after intervention and in a 2 month follow-up. Timepoint: Before, immediately after intervention, 2 month after intervention. Method of measurement: Transvaginal doppler ultrasound.</prim_outcome>
      <prim_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on resistance index of uterine arteries before, immediately after intervention and in a 2 month follow-up. Timepoint: Before, immediately after intervention, 2 month after intervention. Method of measurement: Transvaginal doppler ultrasound.</prim_outcome>
      <prim_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on pulsatility index of uterine arteries before, immediately after intervention and in a 2 month follow-up. Timepoint: Before, immediately after intervention, 2 month after intervention. Method of measurement: Transvaginal doppler ultrasound.</prim_outcome>
      <prim_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on diameter of uterine arteries before, immediately after intervention and in a 2 month follow-up. Timepoint: Before, immediately after intervention, 2 month after intervention. Method of measurement: Transvaginal doppler ultrasound.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on intensity and regularity of menstrual bleeding in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on pelvic tightness or pressure in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on frequent urination during daytime in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on frequent nighttime urination in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on feeling fatigued in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on concerns of patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on activities of patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on energy and mood of patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on control in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on self-consciousness in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
      <sec_outcome>Evaluation and comparison of the effects of Segmental Electroacupuncture, Manual Acupuncture and Sham Acupuncture on sexual function in patients with uterine fibroids before, immediately after intervention and in in a 2 month follow-up. Timepoint: before, immediately after intervention and in in a 2 month follow-up. Method of measurement: UFS-QOL questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-22</approval_date>
        <contact_name>Ethics committee of Mashhad university of medical sciences</contact_name>
        <contact_address>Daneshgah street, Ghorashi building (central building of Mashhad university of medical sciences) Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
